Kairos Pharma

KAPA • XASE

Kairos Pharma is a pharmaceutical preparations company trading on XASE, led by CEO John S. Yu, with a market cap of $12.1M.

CEOJohn S. Yu

Market Cap$12.1M

PHARMACEUTICAL PREPARATIONS

Next Earnings

Upcoming earnings announcement for Kairos Pharma

Date

Wednesday, May 13, 2026 (in a month)

Timing

Before Market Open (6:00 AM New York)

Fiscal Period

Q1 2026

EPS Estimate

-$0.08

Past 5 earnings reports for Kairos Pharma

Date	Period	EPS	EPS Surprise	Revenue	Rev. Surprise	Filing
Nov 14, 2025	Q3 2025	-$0.07Est: -$0.09	+22.2%	-	—	10-Q
Aug 12, 2025	Q2 2025	-$0.08Est: -$0.05	-60.0%	-	—	10-Q
May 14, 2025	Q1 2025	-$0.08	—	-	—	10-Q
Apr 15, 2025	Q4 2024	-$0.08Est: -$0.02	-300.0%	-	—	10-K/A
Nov 14, 2024	Q3 2024	-$0.10	—	-	—	10-Q